Palpitations, Fatigue, Angina More Likely After COVID-19 vs Other Viral Infections
Researchers conducted a study to assess the long-term effects of COVID-19 infection in comparison with other common respiratory viral infections.
Researchers conducted a study to assess the long-term effects of COVID-19 infection in comparison with other common respiratory viral infections.
Results showed vaccine efficacy of 83.7% against RSV-LRTD, defined by 2 or more symptoms.
Nirsevimab is a long-acting anti-RSV for nirsevimab for the prevention of RSV lower.
The approval was based on data from 2 clinical trials that compared Xenoview MRI to xenon Xe 133 scintigraphy in adults with pulmonary disorders.
As part of the Choosing Wisely campaign, the American Academy of Pediatrics (AAP) has released a new list of 5 tests and procedures commonly ordered in pediatric emergency medicine that physicians and patients should question. Choosing Wisely is an American Board of Internal Medicine (ABIM) Foundation initiative that aims to promote discussions between clinicians and…
For regions with high levels of RSV disease activity in the fall and winter, the AAP supports the use of more than 5 consecutive doses of palivizumab to eligible infants.
The vote was mixed when the data was reviewed for younger patients.
The RSVpreF vaccine candidate consists of 2 prefusion F proteins selected to optimize protection against RSV A and B.
Sapanisertib is a dual mTORC 1/2 inhibitor that targets a key survival mechanism in KEAP1/NRF2-mutated tumor cells.
Finerenone, a mineralocorticoid receptor antagonist, may exert anti-inflammatory and anti-fibrotic effects, according to investigators.